Biocartis Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance The grant will support development of next-generation technology for the firm's Idylla platform that would allow for the offline customization of cartridges. Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test The Belgian molecular diagnostics firm also reported a 70 percent year-over-year increase in commercial cartridge volumes in the first quarter. Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer The assay is intended to detect New Products Posted to GenomeWeb: Caris Life Sciences, Qlucore, Biocartis, More Biocartis Reports 15 Percent Rise in 2020 Revenues For the 12 months ended Dec. 31, 2020, Biocartis' revenues rose to €43.1 million ($52.7 million) from €37.4 million in 2019. Nov 12, 2020 Biocartis Q3 Cartridge Volume Grows 61 Percent Nov 10, 2020 Biocartis Gets CE Mark for SARS-CoV-2 RT-PCR Test Nov 4, 2020 Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal Premium Nov 3, 2020 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Oct 29, 2020 Biocartis, Exact Sciences Terminate Oncotype DX Agreement Sep 30, 2020 Biocartis Receives €1.2M Flemish Government Grant to Develop GeneFusion Assay on Idylla Platform Sep 3, 2020 Biocartis H1 Revenues Drop 2 Percent Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Jun 16, 2020 Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage Apr 23, 2020 Biocartis Q1 Cartridge Volume Grows Sharply, Firm Suspends Placements Guidance Mar 26, 2020 Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test Mar 5, 2020 Biocartis Reports 35 Percent 2019 Revenue Rise, New Bristol-Myers Squibb CDx Project Jan 22, 2020 Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement Nov 14, 2019 Biocartis Increases Instrument Placements, Cartridge Volume in Q3; Inks Japan Distribution Deal Oct 25, 2019 New Products Posted to GenomeWeb: Biocartis, Synthego, Sophia Genetics Sep 5, 2019 Biocartis H1 2019 Revenues Rise 39 Percent Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Jun 3, 2019 Biocartis, Kite Sign Development Agreement for Immunotherapy Assays Apr 23, 2019 Biocartis, Covance Sign Commercialization Agreement for Idylla Mar 12, 2019 Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.